Articles tagged "Metabolic complications"

2020 American Transplant Congress
Assessment of Sarcopenia and Obesity by Bioelectrical Impedance Analysis in Transplant and Hepatobiliary Populations
J. Konel¹, T. Kitajima², L. Arevalo¹, N. Murray¹, T. Pietrowsky², D. Venkat², H. Gonzalez², M. Samaniego², M. Abouljoud², S. Nagai²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Transplant Institute, Detroit, MI
*Purpose: Sarcopenia and obesity are common among transplant and hepatobiliary patients; however, current methods of measuring these risk factors may provide an inadequate representation of…
2020 American Transplant Congress
Safety and Effectiveness of Early Initiation of SGLT2 Inhibitors in Diabetic Kidney Transplant Recipients
C. Song¹, R. Winstead¹, A. Brown¹, M. Demehin¹, I. Yakubu¹, I. Moinuddin², G. Gupta²
¹Pharmacy, Virginia Commonwealth University Health, Richmond, VA, ²Virginia Commonwealth University Health, Richmond, VA
*Purpose: Metabolic complications such as post-transplant diabetes (PTDM) are quickly becoming the leading causes of death in kidney transplant (KT) recipients. The use of Sodium…
2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
M. Park¹, Y. Gao¹, S. Schroeder², S. Siyahian¹, Z. Laszik¹, F. Vincenti¹
¹UCSF, San Francisco, CA, ²UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…
2020 American Transplant Congress
Use of Sitagliptin versus Placebo to Reduce the Incidence and Severity of Post-Transplant Diabetes after Kidney Transplantation
H. Wijeweera, J. Hagopian, M. Ramakrishnan, L. Chen, R. Delos Santos
Washington University in St. Louis, Saint Louis, MO
*Purpose: Post-transplant diabetes mellitus (PTDM) is a complication in non-diabetic kidney transplant (KT) recipients due weight gain and use of CNI and corticosteroids in immunosuppression…
2020 American Transplant Congress
The Impact Of Weight Reduction Surgery And Morbid Obesity On Renal Function After Transplantation
S. Negi¹, N. Saberi¹, P. Bouchard², a. Andalib², M. Cantarovich¹, S. Paraskevas¹, J. Tchervenkov¹
¹RIMUHC, Montreal, QC, Canada, ²McGill University, Montreal, QC, Canada
*Purpose: Morbid obesity is a significant barrier and renal transplantation is rarely offered to patients with Class III obesity (body mass index (BMI) > 40…
2020 American Transplant Congress
Early Corticosteroid Withdrawal in Pancreas and Simultaneous Pancreas-Kidney Transplant Recipients: Long-Term Clinical and Metabolic Outcomes of from a Single Center Retrospective Cohort
A. Lichvar, L. Lin, Y. Chen, Y. Yen, D. Pierce, A. Nadeem, P. West-Thielke, I. Tang, J. Almario, M. Spaggiari, I. Tzvetanov, E. Benedetti, M. Campara
University of Illinois at Chicago, Chicago, IL
*Purpose: Tacrolimus, mycophenolate mofetil, and chronic corticosteroids (CCS) are the most popular immunosuppression regimen after pancreas transplantation. Early corticosteroid withdrawal (ECSWD) is an increasingly popular…
2020 American Transplant Congress
Time-Trend of Metabolic Risks in Living Kidney Donors in South Korea
E. Kang¹, J. Park¹, S. Park¹, Y. Kim², J. Jeong³, J. An⁴, S. Lee⁵, S. Kim⁶, J. Cho⁷, M. Han⁸, H. Lee¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Keimyung University Dongsan Hospital, Daegu, Korea, Republic of, ³Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of, ⁴Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea, Republic of, ⁵Internal Medicine, Chonbuk National University Hospital, Jeonju, Korea, Republic of, ⁶Internal Medicine, Chonnam National University Hospital, Gwangju, Korea, Republic of, ⁷Internal Medicine, Kyungpook National University, Seoul, Korea, Republic of, ⁸Internal Medicine, Pusan National University Hospital, Pusan, Korea, Republic of
*Purpose: Considering westernized lifestyles and increasing prevalence of chronic diseases occurred in Korea, time-trend exploration of metabolic risk in live kidney donors may help to…
2020 American Transplant Congress
Incidence and Risk Factors of Post-Transplant Erythrocytosis in Deceased Donor Kidney Transplantation
S. Alasfar, Y. Jia, I. E. Hall, H. Thiessen Philbrook, S. G. Mansour, M. D. Doshi, S. Mohan, J. S. Bromberg, P. P. Reese, C. Parikh
DDS Consortium, Baltimore, MD
*Purpose: Post-transplant erythroytosis (PTE) is clinically important condition after kidney transplantation (KTx). Previously published literature from single-center studies, demonstrated variable incidence rates between 8-15%. We…
2020 American Transplant Congress
Characterization of Use and Safety of Non-Insulin Agents for Management of Post-Transplant Diabetes Mellitus in the Kidney Transplant Population
M. Norris¹, J. Trofe-Clark¹, C. Sammons¹, N. Casciello¹, S. Cardillo², D. Sawinski³, R. D. Bloom³, G. Malat¹
¹Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, ²Endocrine Div, Univ of Pennsylvania, Philadelphia, PA, ³Renal Div, Univ of Pennsylvania, Philadelphia, PA
*Purpose: Newer, non-insulin agents appear to have significant cardiovascular benefits. However, use of these agents for diabetes (DM) management in kidney transplant recipients (KTR) has…
2020 American Transplant Congress
GLP1-RAs, SGLT2i Are Underutilized in Kidney Transplant Recipients with Diabetes Mellitus and Obesity
M. Stumpf, S. A. Dar, S. Rao, A. Doyle
University of Virginia, Charlottesville, VA
*Purpose: There is little research describing differences in use of antidiabetic medications amongst obese, diabetic patients with or without a history of kidney transplant. More…